PAR 6.67% 24.0¢ paradigm biopharmaceuticals limited..

Potential Financial Implications of Yesterday's Results, page-70

  1. 1,695 Posts.
    lightbulb Created with Sketch. 185
    So that is manufacturing cost plus 2% to Bene?
    Thanks for that.
    I think it would be desirable over time to for
    PAR and Bene to have cross shareholding,
    although I know Bene is not publicly listed,
    and Bene is already a small shareholder in
    Bene.

 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
24.0¢
Change
0.015(6.67%)
Mkt cap ! $83.98M
Open High Low Value Volume
22.5¢ 24.0¢ 22.5¢ $173.6K 743.6K

Buyers (Bids)

No. Vol. Price($)
8 99346 22.5¢
 

Sellers (Offers)

Price($) Vol. No.
24.0¢ 131244 5
View Market Depth
Last trade - 16.10pm 13/11/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.